A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population ; volume:10 ; number:1 ; day:26 ; month:6 ; year:2024 ; pages:1-7 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (26.6.2024), 1-7, 12.2024
- Creator
-
Klerk, Gijs W. de
Laar, Teus van
Meles, Sanne K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00739-6
- URN
-
urn:nbn:de:101:1-2409162109300.865281044091
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klerk, Gijs W. de
- Laar, Teus van
- Meles, Sanne K.
- SpringerLink (Online service)
Other Objects (12)
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice